Dupilumab-associated sezary syndrome
Dupilumab is a monoclonal antibody that inhibits interleukin-4 (IL-4) and interleukin-13 (IL-13), approved for the treatment of adults with moderate-to-severe atopic dermatitis (AD). While recent reports have described cases of new-onset mycosis fungoides (MF) following treatment with dupilumab for...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
Wolters Kluwer Medknow Publications,
2023-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_dc48e905d48747a49b4076bca6fdcbf6 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Austin Hamp |e author |
| 700 | 1 | 0 | |a Jamie Hanson |e author |
| 700 | 1 | 0 | |a Albert Alhatem |e author |
| 700 | 1 | 0 | |a Robert A Schwartz |e author |
| 245 | 0 | 0 | |a Dupilumab-associated sezary syndrome |
| 260 | |b Wolters Kluwer Medknow Publications, |c 2023-01-01T00:00:00Z. | ||
| 500 | |a 0019-5154 | ||
| 500 | |a 1998-3611 | ||
| 500 | |a 10.4103/ijd.ijd_580_22 | ||
| 520 | |a Dupilumab is a monoclonal antibody that inhibits interleukin-4 (IL-4) and interleukin-13 (IL-13), approved for the treatment of adults with moderate-to-severe atopic dermatitis (AD). While recent reports have described cases of new-onset mycosis fungoides (MF) following treatment with dupilumab for AD, to our knowledge only one patient has been delineated with the progression to SS. We present an additional case of a patient who was diagnosed with SS following treatment with dupilumab for adult-onset AD and asthma. We examine SS as a possible side effect of dupilumab while also discussing management and theories to explain this phenomenon. | ||
| 546 | |a EN | ||
| 690 | |a atopic dermatitis | ||
| 690 | |a dupilumab | ||
| 690 | |a mycosis fungoides | ||
| 690 | |a sézary syndrome | ||
| 690 | |a Dermatology | ||
| 690 | |a RL1-803 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Indian Journal of Dermatology, Vol 68, Iss 4, Pp 459-462 (2023) | |
| 787 | 0 | |n http://www.e-ijd.org/article.asp?issn=0019-5154;year=2023;volume=68;issue=4;spage=459;epage=462;aulast=Hamp | |
| 787 | 0 | |n https://doaj.org/toc/0019-5154 | |
| 787 | 0 | |n https://doaj.org/toc/1998-3611 | |
| 856 | 4 | 1 | |u https://doaj.org/article/dc48e905d48747a49b4076bca6fdcbf6 |z Connect to this object online. |